Biography
Dr. Tommaso Pollini, M.D. is a post-doctoral research fellow at the University of California, San Francisco (UCSF) in the Maker Lab, specializing in pancreatic cystic neoplasms with a focus on Intraductal Papillary Mucinous Neoplasms (IPMN). He completed his surgical training at the Pancreas Institute of the University of Verona, Italy, where he developed a solid foundation in pancreatic diseases. Recognized for his contributions to the field, Dr. Pollini received the prestigious Kenneth Warren Fellowship from the International Hepato-Pancreato-Biliary Association and the Steve Sotsky Award from the American Hepato-Pancreato-Biliary Association.
At UCSF, his research centers on developing predictive models for high-grade dysplasia in pancreatic cystic tumors using machine learning. Utilizing his expertise in bioinformatics, single-nucleus RNA sequencing (snRNAseq), and spatial transcriptomics, he studies the tumor immune microenvironment of pancreatic cancers. Dr. Pollini has published his work in leading journals such as JAMA Surgery, The Lancet Gastroenterology & Hepatology, and Gastroenterology, contributing significantly to advancements in pancreatic cancer research.
Education
Institution | Degree | Dept or School | End Date |
---|---|---|---|
University of Verona | General Surgery Residency | 01/2023 | |
University of Verona | Research Fellow at the Department of General and Pancreatic Surgery of the Pancreas Institute | 12/2017 | |
University of Verona | MD | Medicine | 10/2015 |
Awards & Honors
Award | Conferred By | Date |
---|---|---|
Kenneth Warren Fellowship | International Hepato-Pancreato-Biliary Association (IHPBA) | 2021/2022 |
Steve Sotksi Award | American Hepato-Pancreato-Biliary Association (AHPBA) | 2021 |
Publications
- Artificial intelligence-based models to assess the risk of malignancy on radiological imaging in patients with intraductal papillary mucinous neoplasm of the pancreas: scoping review.| | PubMed
- Concomitant Serous Cystadenoma and Intraductal Papillary Mucinous Neoplasm in Pancreatic Cysts-a Diagnostic and Surgical Dilemma.| | PubMed
- Surveillance for Presumed BD-IPMN of the Pancreas: Stability, Size, and Age Identify Targets for Discontinuation.| | PubMed
- It is not necessary to resect all mucinous cystic neoplasms of the pancreas: current guidelines do not reflect the actual risk of malignancy.| | PubMed
- Drain Placement After Pancreatic Resection: Friend or Foe For Surgical Site Infections?| | PubMed
- The Landmark Series: Intraductal Papillary Mucinous Neoplasms of the Pancreas-From Prevalence to Early Cancer Detection.| | PubMed
- The tumour immune microenvironment and microbiome of pancreatic intraductal papillary mucinous neoplasms.| | PubMed
- Actual malignancy risk of either operated or non-operated presumed mucinous cystic neoplasms of the pancreas under surveillance.| | PubMed
- The use of a mobile application to disseminate guidelines on cystic neoplasms of the pancreas - A snapshot study of 1000 case-simulations.| | PubMed
- Progression vs Cyst Stability of Branch-Duct Intraductal Papillary Mucinous Neoplasms After Observation and Surgery.| | PubMed